Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Proc Natl Acad Sci U S A
Logging consistently matters not just to know when you dosed, but to correlate your protocol with actual outcomes like sleep scores, training performance, and body composition
Always consult qualified healthcare providers before beginning any research protocol
Additionally, FOXO4-DRI reduced the DHE-positive cell count, indicating decreased ROS levels under OGD conditions (Figure 4F)
Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters
BOOK HERE - only available at NatCan Integrative Medical and Wellness Centre
